About Us

Molsentech is redefining the future of precision detection!

We are fully committed to promoting the popularization of early disease detection, prevention, and precision health management. Through our world-leading Bio-FET semiconductor biochip detection platform, we provide healthcare decision-makers and the public with faster, more accurate, and more accessible test results. Our ultra-sensitive biochips can precisely detect diseases such as cancer and dementia in their nascent stages, enabling patients to intervene with more affordable and effective treatments. This helps avoid costly and complex late-stage therapies, while simultaneously improving detection efficiency, reducing medical costs and social burdens, and truly safeguarding public health. We plan to build a global disease surveillance platform, partnering with governments worldwide to deploy rapid, scalable biochip detection stations at key entry points like airports, ports, and borders. By identifying infected individuals before cross-border transmission occurs, we can lower the reproduction number (R₀), buy precious time for vaccine development and public health responses, prevent local outbreaks from evolving into global pandemics, and save more lives. At Molsentech, we are forging cutting-edge precision detection technologies, laying the future cornerstone for human health: precisely sensitive, intelligently advanced, and swiftly efficient.